For example, SCLC cell lines with MYC, MYCN, and MYCL1 activation or amplification were the most sensitive in a viability screen of 87 cell lines using the dual Aurora A and Aurora B kinase inhibitor PF-03814735 (39). Here, MYCN is linked to small cell lung carcinoma.